Wrsu, anascorp injections

Ended Awarded Last action

Contract number
HHSI247201800002G
Awardee
Awarding agency
Obligated
$16,640

Award facts

Opportunity
  • IHS1338923 Solicitation number
Contract value 100% obligated
$16,639.98 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Whiteriver, AZ 85941, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00004 · Deobligate residual funds and close out contract. -$26,861
Supplemental Agreement for work within scope P00003 $1,811
Supplemental Agreement for work within scope P00002 $16,700
Funding Only Action 1 $8,350
Original award $16,640

Quick answers

Who was awarded contract HHSI247201800002G?

HHSI247201800002G was awarded to Rare Disease Therapeutics, Inc. by Indian Health Service (Department of Health and Human Services) on November 14, 2017.

How much is contract HHSI247201800002G worth?

The government has obligated $16,640 on HHSI247201800002G.

Is contract HHSI247201800002G an order under another contract?

Yes. HHSI247201800002G is a delivery order under V797P5195B, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract HHSI247201800002G competed?

The extent of competition for HHSI247201800002G was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award